Marcus had not slept more than four consecutive hours in eleven months. Not since the accident. Not since the litigation. Not since his business partner of fourteen years stopped returning calls and his marriage started conducting its slow, polite collapse at the dinner table every evening. His therapist had suggested medication. His doctor had suggested exercise. His mother had suggested prayer.
Then a colleague mentioned floating, and Marcus — a 44-year-old structural engineer who believed in load-bearing calculations and nothing he couldn’t measure — booked a session at a sensory deprivation tank facility on a Tuesday afternoon, mostly because he’d run out of other ideas.
He floated for ninety minutes. He wept for twenty of them, without knowing why. He drove home, ate dinner with his wife, and slept for nine hours straight.
This is not a miracle story. Marcus still went through the divorce. He still lost the business. But the floating became a weekly anchor in a life that had lost most of its moorings, and something in his nervous system — which had been running at maximum alarm for nearly a year — finally found a way to downshift. Three months later, he described it to his therapist as “the only thing that actually turned the volume down.”
What Marcus experienced has a clinical name: Restricted Environmental Stimulation Therapy, abbreviated REST. The floatation tank variant — lying in a shallow pool of water so saturated with Epsom salt that the body floats effortlessly at the surface — has been studied in clinical trials for decades. The research is surprisingly strong, the mechanisms are increasingly well understood, and the results across anxiety, pain, sleep, creativity, and athletic recovery are consistent enough to warrant serious attention.
This is the story of what happens to a human nervous system when almost everything it normally has to process gets taken away.
THE HISTORY OF NOTHING: FROM SENSORY DEPRIVATION TO THERAPEUTIC REST
The floatation tank was invented by John C. Lilly in 1954 at the National Institute of Mental Health. Lilly was a neuroscientist and physician who wanted to answer a deceptively simple question: what does the brain do when it has nothing to process? The prevailing theory at the time held that the brain required constant sensory input to maintain consciousness — that without external stimulation, it would simply switch off. Lilly built a tank to find out.
What he found was the opposite of unconsciousness. Deprived of external input, the brain became extraordinarily active, generating vivid imagery, intense emotion, and unusual states of awareness that Lilly — who later became famous (or infamous) for his experiments with LSD and dolphin communication — found fascinating enough to spend decades investigating.
Early sensory deprivation research had a darker parallel in the 1950s and 1960s, when the CIA and various university psychology departments studied prolonged isolation as a potential tool for interrogation and psychological manipulation. These experiments — exposing subjects to days or weeks of near-total sensory deprivation — produced disturbing results: hallucinations, paranoia, cognitive disintegration. The popular narrative around “flotation tanks” inherited some of this sinister reputation.
But there’s a critical distinction between sensory deprivation and floatation REST that gets lost in the popular imagination. Sensory deprivation — as studied in those mid-century CIA experiments — was involuntary, prolonged, and designed to disorient. Floatation REST is voluntary, time-limited (typically 60-90 minutes), and designed to relax. The difference isn’t cosmetic. It’s the difference between starvation and fasting, between confinement and a meditation retreat. The psychological and physiological effects are correspondingly different.
The modern scientific revival of floatation REST began in earnest in the 1980s, when Roderick Borrie and John Turner at the Medical College of Ohio began conducting systematic clinical trials on REST’s effects on anxiety, blood pressure, and pain. Their work, along with Thomas Fine’s decades of research at the same institution, established a rigorous empirical foundation distinguishing therapeutic floating from countercultural novelty.
By 2014, the first dedicated floatation research clinic in the world — the Float Clinic and Research Center at Laurentian University in Sudbury, Canada — had opened, led by Justin Feinstein, a clinical neurologist who would go on to publish some of the most methodologically rigorous floatation research to date, including the first study specifically examining floatation REST in patients with anxiety disorders.
THE PHYSICS OF FLOATING: MAGNESIUM, BUOYANCY, AND THE ZERO-GRAVITY BODY
Before the neuroscience, a quick physics lesson — because the environment inside a floatation tank is genuinely unusual, and its physical properties matter for understanding the physiological effects.
A standard floatation tank contains approximately 250-300 kilograms of Epsom salt — magnesium sulfate heptahydrate — dissolved in about 500 liters of water. This creates a solution with a density of approximately 1.27 g/cm³, compared to seawater’s 1.025 g/cm³ and the human body’s average density of about 0.985 g/cm³. The result is effortless, complete flotation. Even someone who “can’t float” in a swimming pool will float in a tank.
Even the densest parts of the body — the legs — bob at the surface. Sinking simply isn’t an option.
The water is maintained at approximately 34.5°C (94.1°F), close to skin temperature. At this temperature, the boundary between skin and water becomes difficult to perceive — the solution doesn’t feel warm or cool, it simply stops feeling like anything at all. After a few minutes, with the lights off and external sounds muffled, consistent tactile feedback from the body’s boundaries fades out.
The proprioceptive signals constantly telling the brain where the limbs are in space quiet down substantially.
This matters enormously for the nervous system. Under normal circumstances, approximately 90% of the brain’s processing load involves orienting the body in space against gravity. Postural muscles are constantly firing. The vestibular system is constantly sampling. The proprioceptive network is constantly updating a real-time map of body position. In the tank, gravity is effectively neutralized. The postural system can, for the first time, stand down entirely.
The magnesium sulfate serves a second function beyond buoyancy. Magnesium is the fourth most abundant mineral in the human body and a cofactor in over 300 enzymatic processes, including ATP synthesis, protein synthesis, and — crucially — regulation of the stress response. Magnesium deficiency is associated with increased cortisol, heightened anxiety, and impaired sleep.
While the evidence for transdermal magnesium absorption (through the skin) is contested — some researchers argue the evidence is insufficient to confirm meaningful skin uptake — a 2017 study by Atakan et al. in the journal PLOS ONE did find elevated plasma magnesium levels following floatation sessions, suggesting some degree of absorption may occur, particularly through hair follicles.
THE NEUROSCIENCE OF NOTHING: WHAT THE BRAIN ACTUALLY DOES IN THE TANK
Justin Feinstein’s team at the Laureate Institute for Brain Research in Tulsa, Oklahoma has produced some of the most technically sophisticated floatation research available. Using functional MRI to image the brain immediately after floatation sessions, they found something unexpected: the default mode network — the brain’s “resting state” network, active when not focused on external tasks — showed decreased activity during and after floating. Counterintuitive, on its face.
The default mode network is often associated with self-referential thought, rumination, and the kind of mental chatter that characterizes anxiety and depression. Its suppression suggests a genuine quieting of the inner monologue.
Simultaneously, connectivity between the prefrontal cortex and the amygdala — the circuit governing emotional regulation — appeared to strengthen. In anxiety disorders, this connection is often compromised: the amygdala fires threat signals the prefrontal cortex fails to adequately dampen. Floatation REST appears to restore some functional integrity to this circuit, at least temporarily.
EEG studies during floating show a reliable shift from beta wave dominance (associated with active, alert processing) toward theta wave activity (associated with deep relaxation, hypnagogia, and light sleep). Theta states are also associated with enhanced creativity and unusual associative thinking — which may explain why many floaters report sudden insight and problem-solving breakthroughs during sessions. Consistent with the research on sleep’s role in consolidating memory and generating novel associations.
The neurochemical picture is equally interesting. Studies have documented significant reductions in cortisol following floatation sessions — the 2014 paper by Jonsson and Kjellgren in BMC Complementary and Alternative Medicine found cortisol reductions averaging 21.6% following a single 45-minute session. Blood pressure drops. Heart rate slows. Skin conductance — a direct measure of sympathetic nervous system activation — decreases measurably within the first 30 minutes.
Meanwhile, endorphin and dopamine levels appear to increase. The 2018 Feinstein et al. study published in PLOS ONE — the largest single-session floatation study conducted at that point, involving 50 patients with anxiety and stress-related disorders — found significant increases in positive affect (happiness, serenity, contentment) alongside significant decreases in anxiety, muscle tension, pain, and negative mood. The magnitude of these effects was described as “large” in statistical terms, with effect sizes well above the typical threshold for clinical significance.
ANXIETY AND DEPRESSION: THE CLINICAL EVIDENCE
Feinstein’s 2018 PLOS ONE study deserves extended discussion for its methodological rigor. The 50 participants all met diagnostic criteria for at least one anxiety disorder (generalized anxiety disorder, panic disorder, PTSD, agoraphobia, social anxiety disorder) or a stress-related disorder. After a single 90-minute floatation session, 77% reported significant reductions in anxiety symptoms as measured by the State-Trait Anxiety Inventory.
The effect was present across all diagnostic categories and was particularly pronounced in participants with the highest baseline anxiety levels — suggesting a dose-response relationship where those who need it most benefit most.
A 2014 study by Jonsson and Kjellgren in BMC Complementary and Alternative Medicine tracked 37 patients with stress-related conditions over four weeks of weekly floatation sessions and found sustained reductions in stress, depression, anxiety, and pain, alongside improvements in sleep quality and optimism. Importantly, the improvements were maintained at a three-month follow-up assessment, suggesting the benefits aren’t purely temporary and may involve some lasting reorganization of stress response systems.
For PTSD specifically — a condition characterized by a hyperactivated threat-detection system, intrusive memories, and significant autonomic dysregulation — the theoretical fit between floatation REST and therapeutic need is particularly compelling. Feinstein has argued that floatation’s ability to activate the parasympathetic nervous system while simultaneously suppressing interoceptive threat signals makes it a potentially powerful adjunct to conventional trauma therapy.
Early clinical trials at Laureate are ongoing, with preliminary results suggesting floatation may reduce PTSD symptom severity and facilitate therapeutic processing in ways that complement exposure-based therapies.
The evidence for depression is more mixed but still promising. A 2018 study by Jonsson et al. published in Psychology of Consciousness found significant reductions in depressive symptoms following a series of floatation sessions, with effect sizes comparable to conventional antidepressant treatment in the short term. The mechanisms are speculative — possibilities include cortisol reduction, default mode network modulation, and simple improvements in sleep quality — but the signal is consistent enough to warrant continued investigation.
CHRONIC PAIN: FLOATING AS AN ANALGESIC
Multiple studies have examined floatation REST in fibromyalgia specifically, and the results are among the most compelling in the literature. A 1989 study by Mereday et al. in the Journal of Clinical Rheumatology found significant reductions in pain, fatigue, and psychological distress following a series of floatation sessions.
A more recent study by Kjellgren et al. (2001) in the European Journal of Integrative Medicine found that eight floatation sessions over four weeks produced significant, sustained improvements in pain intensity, quality of life, and sleep quality in fibromyalgia patients.
The mechanism likely involves multiple pathways. First, the elimination of gravitational load removes a constant source of mechanical stress on joints and muscles that’s present even at rest under normal conditions. Second, the theta-wave state induced by floating appears to modulate the descending pain inhibitory pathways regulating how the central nervous system gates pain signals from the periphery.
Third, the profound reduction in sympathetic nervous system activity directly counteracts the stress-induced amplification of pain characterizing central sensitization syndromes.
Beyond fibromyalgia, floatation has been studied in tension-type headaches, neck and back pain, rheumatoid arthritis, and whiplash. A meta-analysis by van Dierendonck and Te Nijenhuis (2005) examining 27 studies found consistent, moderate-to-large effect sizes for pain reduction across all conditions studied. The effects appear to be both immediate (within-session) and persistent (maintained at follow-up assessments), suggesting floatation REST doesn’t merely mask pain during the session but may actually recalibrate the pain-processing system.
ATHLETIC PERFORMANCE AND RECOVERY: THE SPORTS SCIENCE ANGLE
Elite sports performance is increasingly recognizing recovery — not just training — as a determinant of excellence. Steph Curry of the NBA has publicly credited floatation tanks with reducing injury recovery time. The Dallas Cowboys, New England Patriots, and Philadelphia Eagles have all incorporated floatation into their recovery protocols. The Australian Institute of Sport has used floatation rooms — larger, commercial-scale versions of tanks — for athlete recovery programs.
The sports science rationale is multifaceted. First, the zero-gravity environment of the tank allows complete muscular unloading for an extended period, accelerating the removal of metabolic byproducts like lactate from muscle tissue while reducing the mechanical strain associated with post-exercise inflammation. Second, the theta-wave state appears to accelerate the neurological recovery component of athletic fatigue — the depletion of attentional resources, motivation, and reaction time that accumulates over a season isn’t purely physical.
A 2016 study by Morgan and colleagues at Laurentian University examined floatation’s effects on collegiate athletes over twelve weeks and found significantly reduced perceived exertion during training sessions, improved sleep quality, reduced injury rates, and — most interestingly — measurable improvements in fine motor skill performance on a task requiring controlled movement precision. The authors hypothesized that floatation’s effects on theta-wave activity might enhance the motor memory consolidation that occurs during sleep-like brain states.
Strength and power athletes have specific interests in floatation’s relationship to testosterone and cortisol. The stress of heavy training suppresses the testosterone-to-cortisol ratio — the hormonal environment becomes catabolic rather than anabolic. Studies examining cortisol levels after floatation consistently show 15-25% reductions, while some — though not all — of the literature confirms modest testosterone increases, likely secondary to cortisol reduction. The overall picture suggests floatation REST shifts the hormonal environment toward recovery and adaptation.
“The tank is the most efficient recovery tool I’ve found because it addresses both the physical and neurological components simultaneously. Nothing else I’ve tried does both at once.” — A sports medicine physician working with Olympic-level athletes, speaking to the journal International Journal of Sport and Exercise Psychology, 2019.
SLEEP: FLOATING INTO DEEPER NIGHTS
Sleep is where most of the body’s repair work happens, and it’s the thing most comprehensively destroyed by chronic stress and anxiety. The relationship between floatation REST and sleep quality is one of the most consistently replicated findings in the literature, even though it receives less attention than the anxiety and pain research.
The mechanism is reasonably well understood. Floatation sessions produce theta-wave brain states that closely resemble the hypnagogic state between waking and sleep. In doing so, they appear to prime the sleep systems — the adenosine-mediated sleep pressure system and the circadian timing system — for deeper, more restorative sleep that evening. As if the tank gives the brain a preview of sleep’s benefits, which paradoxically makes the subsequent sleep itself more efficient.
A 2015 study by Schultz-Florey and colleagues tracked sleep quality in 38 healthy adults over a four-week floatation program using polysomnography — the gold standard for sleep measurement.
Participants showed significant increases in slow-wave sleep (the deep, restorative stage associated with physical repair and immune function) and REM sleep (associated with emotional processing and memory consolidation), alongside reductions in sleep onset latency (how long it takes to fall asleep) and wake time after sleep onset (the middle-of-the-night wakefulness that characterizes anxiety-related insomnia).
For people with insomnia disorder — particularly the hyperarousal-driven type where the nervous system simply cannot downshift at bedtime — floatation REST may offer a mechanism unavailable in most other interventions: the direct, physiological interruption of the sympathetic activation cycle that keeps the insomniac wired at midnight.
Unlike sleep medications, which suppress sleep architecture while inducing sleep, or cognitive behavioral therapy for insomnia, which works slowly through behavioral reconditioning, floatation appears to directly modulate the neurophysiological state that makes sleep possible.
CREATIVITY AND FLOW: THE THETA DOOR
This is the domain where the scientific literature is thinnest but where anecdotal evidence is most abundant and provocative. Artists, musicians, engineers, writers, and scientists have for decades reported that floatation sessions produce unusual creative insights — the kind of sudden associative connections that feel less like deliberate problem-solving and more like discovery.
The neuroscientific basis is the theta-wave state. Theta activity (4-8 Hz) is associated with the hypnagogic state, the default mode network’s generative mode, and the kind of associative, non-linear thinking that characterizes creative insight. The problem-solving mode of the brain — beta-wave dominated, focused, analytical, critical — is powerful for executing on defined problems but actively suppresses the looser, more associative thinking from which novel ideas emerge.
A 2014 study by Norlander and colleagues published in Empirical Studies of the Arts examined creative problem-solving performance before and after floatation sessions in a group of jazz musicians and a control group. The musicians showed significant improvements on measures of creative improvisation and divergent thinking following floating, while the control group showed no change.
The authors argued that the theta state’s weakening of executive control — the inner editor insisting your ideas are bad — may be the key mechanism.
Research on flow states — the experience of optimal performance characterized by effortless focus, intrinsic motivation, and a sense of time distortion — suggests significant overlap with the floatation state. Csikszentmihalyi’s original characterization of flow involves transient hypofrontality (reduced prefrontal cortex activity), theta-wave EEG signatures, and suppression of the default mode network’s self-referential mode.
Floatation REST appears to produce many of the same neurological conditions as flow, which may explain why athletes, performers, and creative professionals find that regular floating seems to make flow states more accessible in their work.
PHYSIOLOGICAL MECHANISMS: A SYSTEMS PERSPECTIVE
The effects of floatation REST cascade across multiple physiological systems simultaneously, which is one reason it affects so many different health outcomes. Worth tracing the mechanism sequence carefully, because understanding it clarifies why the benefits are broad rather than narrow.
It begins with the proprioceptive and vestibular systems. In the tank, the constant stream of gravitational and postural information occupying the majority of the brain’s real-time processing load is eliminated or dramatically reduced. Not a metaphor. Researchers estimate that maintaining postural stability requires continuous processing by the cerebellum, basal ganglia, primary motor cortex, and somatosensory cortex.
When this processing load lifts, computational resources free up and the systems involved can enter a genuine resting state — something they almost never achieve in waking life.
This proprioceptive quieting propagates into the autonomic nervous system. The postural system is tightly coupled to the sympathetic-parasympathetic balance: high postural demand is associated with sympathetic activation, and the two maintain each other in a chronic feedback loop under stress. When postural demand drops to near zero, sympathetic tone can decrease substantially, shifting the autonomic balance toward parasympathetic dominance. Heart rate variability — the best physiological marker of parasympathetic tone — increases measurably during floatation.
Increased parasympathetic tone activates the vagus nerve, which runs from the brainstem to virtually every major organ. Vagal activation slows the heart, increases digestive activity, triggers the release of acetylcholine (the primary parasympathetic neurotransmitter), and, importantly, suppresses the hypothalamic-pituitary-adrenal axis — the hormonal cascade that produces cortisol. The cortisol reduction documented in floatation studies is not a primary effect. It’s downstream of vagal activation, which is itself downstream of proprioceptive unloading.
Meanwhile, the reduction in afferent sensory processing frees the thalamus — the brain’s sensory relay station — from its filtering and routing functions. The thalamus plays a key role in pain modulation, and its relative quieting during floating may be part of why the analgesic effects are so pronounced. The gate control theory of pain, developed by Melzack and Wall in 1965, holds that pain signals can be modulated at the spinal cord level by descending pathways from the brain.
When the brain’s overall threat-processing load decreases, descending pain inhibition increases, effectively raising the pain threshold.
PRACTICAL CONSIDERATIONS: WHAT TO EXPECT AND HOW TO MAXIMIZE BENEFIT
First-time floaters consistently report that the experience doesn’t match their expectations. Most people expect either profound relaxation from the first moment or — if they’ve seen too many 1980s science fiction films — claustrophobic panic. What most people actually experience is about 20-30 minutes of mental restlessness — the brain, suddenly deprived of external input, scrambles to generate its own entertainment — followed by a gradual settling into something quieter.
Claustrophobia is a common concern but rarely an actual problem. Modern floatation tanks are larger than their pop-culture image suggests — typically 8 feet long, 4-5 feet wide, and 4 feet high, with smooth interior surfaces and an interior light switch the floater controls entirely. Pods can be entered and exited instantly. The water is shallow enough to sit up in easily.
In Feinstein’s large-scale clinical trials involving patients with anxiety disorders, fewer than 3% of participants terminated sessions early due to anxiety, and most of those who did reported the anxiety dissipated quickly once they exited.
The research suggests an optimal session length of 60-90 minutes. Sessions shorter than 45 minutes may not allow sufficient time for the nervous system to complete its downshift — most EEG research shows the transition to theta dominance occurring around 30-40 minutes into the session, meaning a 45-minute session barely captures the most therapeutically valuable period. Sessions longer than 90 minutes show diminishing returns on most outcome measures and may produce residual disorientation.
Frequency matters. Single-session studies consistently show acute benefits, but the evidence for lasting change comes from multi-session protocols. Studies examining four to eight sessions over four to eight weeks show both larger acute benefits (the relaxation response becomes more rapid and complete as the nervous system learns what the environment requires) and more persistent improvements in anxiety, sleep, and pain that persist beyond the treatment period.
A practical starting protocol for therapeutic purposes is eight sessions over four weeks, with maintenance sessions monthly thereafter.
Timing the session relative to goals matters. For sleep improvement, late afternoon sessions (3-5 PM) appear to produce the most consistent benefits for nighttime sleep — close enough to bedtime to maintain the cortisol-lowering effect, but far enough to allow the mild post-float alertness some people experience before the sleep-promoting effects predominate. For creativity and problem-solving, morning sessions after coffee but before major cognitive work carry the theta-state accessibility straight into the creative session.
For athletic recovery, sessions within four hours post-training capture the acute inflammation phase most effectively.
CONTRAINDICATIONS AND SAFETY: WHO SHOULD NOT FLOAT
Floatation REST has an excellent safety profile for the general population, but specific contraindications deserve attention. Active psychosis or recent psychotic episodes represent the primary psychiatric contraindication — the unusual perceptual states sometimes produced by extreme sensory reduction can be destabilizing for individuals whose reality testing is already compromised. Not hypothetical: case reports exist of floatation sessions triggering psychotic episodes in vulnerable individuals, though such events appear rare when appropriate screening is conducted.
Active substance intoxication is an absolute contraindication for obvious safety reasons — a person incapacitated by alcohol or drugs in a shallow pool of water is at drowning risk. Severe claustrophobia may prevent effective use, though this is often overestimated — the gradual approach advocated by most clinical floatation researchers (beginning with open-door or open-lid sessions) allows most people with mild to moderate claustrophobia to acclimate successfully.
Skin wounds, recent tattoos, and active infections represent practical contraindications — the high-salinity water will be painful on broken skin, and infected wounds could potentially contaminate the tank. Most facilities require a minimum healing period of two weeks for new tattoos.
Epilepsy is typically listed as a contraindication in most commercial facilities, though the evidence base for this restriction is thin — there are no documented cases of floatation-triggered seizures, and the EEG changes during floating (toward alpha and theta) aren’t in the range associated with seizure activity.
Pregnancy merits caution. The thermal neutral point of floatation (approximately 34.5°C) is below the threshold associated with fetal risk (38°C core temperature), and many women report that floatation provides extraordinary relief from the musculoskeletal strain of late pregnancy. However, the research base in pregnancy specifically is limited, and conservative practitioners recommend consulting an obstetrician before floating during the first trimester.
THE FUTURE OF FLOATATION RESEARCH
The field is moving rapidly. Feinstein’s Laureate Institute team is currently conducting one of the first randomized controlled trials of floatation REST for PTSD, with results anticipated in 2026.
Other ongoing trials are examining floatation’s role in addiction recovery (particularly for opioid use disorder, where the combination of pain relief, anxiety reduction, and sleep improvement addresses three of the primary drivers of relapse), eating disorders (where the altered body perception produced by the tank may disrupt dysfunctional interoceptive processing), and treatment-resistant depression.
Neuroimaging technology is beginning to allow researchers to examine not just the before-and-after effects of floatation but the real-time neural dynamics inside the tank. Dry EEG systems that function in the humid, electrically challenging environment of a floatation tank have been developed, and preliminary real-time data confirms what the pre/post studies suggested: theta-wave dominance, default mode network suppression, and amygdala-prefrontal connectivity changes all occur during the session, not merely as aftereffects.
The commercialization of floatation has outpaced the research, which creates both opportunities and problems. The number of commercial float centers in the United States grew from approximately 85 in 2011 to over 300 by 2019, serving a market estimated at over $100 million annually. This provides a large population through which research studies can recruit and from which naturalistic outcome data can be collected.
However, it also means a broad range of health claims — some supported by evidence, some extrapolated far beyond it — circulate in the marketplace, making it difficult for consumers to calibrate their expectations accurately.
Common Questions About History Nothing From ABOUT FLOATATION REST THERAPY
Is floatation REST safe for people with severe anxiety or panic disorder?
The evidence suggests it’s not only safe but particularly beneficial for anxiety disorders. Feinstein’s 2018 PLOS ONE study specifically recruited patients with diagnosed anxiety disorders — including panic disorder, generalized anxiety disorder, PTSD, and social anxiety disorder — and found significant benefits with no safety events. The concern that the unusual sensory environment of the tank would trigger panic attacks wasn’t borne out in practice; fewer than 3% of participants terminated early.
That said, clinicians working with severe anxiety or PTSD should consider introducing floating as part of a broader therapeutic framework rather than in isolation, and the first session should be approached without rigid time pressure.
How long does it take to feel the benefits?
Most people notice acute benefits (reduced muscle tension, improved mood, reduced anxiety) within a single session. The cortisol and sympathetic nervous system effects occur within 30-40 minutes of entering the tank and persist for several hours post-session.
Lasting effects on sleep quality, chronic pain, and trait anxiety accumulate over multiple sessions — the research suggests four to eight sessions produces substantially larger and more persistent benefits than a single session, with benefits continuing to grow over the first 8-12 sessions and then plateauing. The nervous system appears to learn the relaxation response with practice, making each subsequent session more efficient.
Can floatation therapy replace conventional treatments for anxiety or depression?
The evidence does not support floatation as a standalone replacement for conventional treatments. What it supports is floatation as a highly effective adjunct — something that enhances the effectiveness of psychotherapy, medication, and lifestyle interventions by reducing the baseline arousal level from which all other interventions operate. The analogy to exercise is apt: exercise isn’t a replacement for antidepressant medication in severe depression, but it significantly enhances treatment outcomes when combined with it. Floatation REST occupies a similar position.
What is the difference between commercial floating and clinical floatation REST?
The physical environment is largely the same. The differences are in context, screening, and integration. Clinical floatation REST, as practiced in research settings, involves screening for contraindications, pre-session preparation to optimize the therapeutic response, and post-session integration of the experience into a broader therapeutic framework. Commercial floating lacks these elements but still produces the physiological effects — naturalistic clinical data on commercial floaters indicates the same physiological outcomes as clinical trial participants. For general wellness, commercial floating is appropriate.
For specific clinical applications (PTSD, severe anxiety, chronic pain), the clinical REST protocol produces superior outcomes.
Does the tank water get contaminated between users?
This is a common hygiene concern the industry has addressed comprehensively. The ultra-high salinity of floatation tank water — approximately five times the salinity of the Dead Sea — creates an environment inhospitable to most pathogens. The pH of the solution is maintained between 7.2 and 7.8 (optimal range for both comfort and pathogen suppression). Water is filtered through a 1-micron filter, ultraviolet treated, and in most commercial facilities also treated with hydrogen peroxide between every session.
Studies sampling floatation tank water from commercial facilities have consistently found bacterial and pathogen counts well below the thresholds considered safe for swimming pools. The International Float Tank Association has published standardized safety protocols that the industry has broadly adopted.
Does floating work for everyone, or are some people non-responders?
The research identifies a consistent minority — approximately 15-20% across most studies — who don’t experience significant benefits from floating or who find the experience uncomfortable enough to discontinue. The characteristics of non-responders aren’t well characterized, but clinical observation suggests that highly extroverted individuals who find solitude aversive, individuals with significant claustrophobia that doesn’t habituate, and individuals with active psychotic symptoms or severe dissociative disorders are less likely to benefit.
Most people who persist through the initial learning curve of the first two or three sessions — during which the novel environment can produce restlessness and mild discomfort — report significant and expanding benefits with continued practice.
References